LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cellsYongfang Ma(Anhui University of Science and Technology), Xiaolong Tang(Anhui University of Science and Technology)International Journal of Medical SciencesJanuary 1, 202110.7150/ijms.51256Cited by 38SaveCiteExport RISWatch citationsRelated PapersETS-1/c-Met drives resistance to sorafenib in hepatocellular carcinoma.|PubMed|2023|4